The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
i guess the questions that are always going to be kind of and they vary probably test by test mutation by mutation is is the test sensitive enough in this case if you find you don't have the mutation on the liquid test are you still going to want to go get tumor tissue or do you need to get tumor tissue for another reason to figure out the subtype and in that case you might as well you already have the information you need
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.